SMC Ltd. and Oval Featured on MPMN Medtech Pulse

“Oval’s autoinjectors offer pharma companies clear differentiation from their competitors through innovative design and offer benefits including accurate dosing with high viscosity formulations and improved stability for biologics within small, intuitive-to-use devices for patients,” Read how SMC and Oval are working together on the next generation of Autoinjectors. Read the full article here: http://www.qmed.com/mpmn/medtechpulse/new-autoinjector-options-emergency-use-drugs?cid=nl.x.qmed02.edt.aud.qmed.201701242